Chiropractors in Kennebunk, ME Accepting Medicare

11 Chiropractors found. Showing 1 - 11

Family Chiropractic Of Kennebunk, Pa Chiropractor Medicare: Medicare Enrolled Practice Location: 44 York St, Kennebunk, ME 04043 Phone: 207-985-8877    Fax: 207-985-5683

Dr. Erika Kristin Bruns Montemerlo, D.C. Chiropractor - Independent Medical Examiner Medicare: Not Enrolled in Medicare Practice Location: 2 Christensen Ln, Kennebunk, ME 04043 Phone: 207-356-8688

Dr. Denise T Couture, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 401 Lafayette Ctr, Kennebunk, ME 04043 Phone: 207-985-7133    Fax: 207-985-7134

Andrew Michael Bruns, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 2 Christensen Ln Ste 1, Kennebunk, ME 04043 Phone: 207-249-9986    Fax: 207-888-9592

Meghan Schoening, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8 Penny Ln, Kennebunk, ME 04043 Phone: 207-229-8997

Kennebunk Chiropractic, Pa Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 56 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-2900    Fax: 207-985-5531

Clifford Lewis Faldman, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 62 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-3780    Fax: 207-985-2933

Dr. Timothy Bernard Bruhl, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 56 Portland Rd, Kennebunk, ME 04043 Phone: 207-985-2900    Fax: 207-985-5531

Faldman Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 62 Portland Rd, Suite 47, Kennebunk, ME 04043 Phone: 207-985-3780    Fax: 207-985-2933

Colby Wilson, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2 Storer St Ste 401, Kennebunk, ME 04043 Phone: 207-985-7133

Dr. Pedro P. Gay, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 44 York St, Kennebunk, ME 04043 Phone: 207-985-8877    Fax: 207-985-5683

News Archive

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE).

Delta variant surges in Colorado as the bands play on

Dr. Rachel LaCount grasped a metal hoop at a playground and spun in circles with her 7-year-old son, turning the distant mesas of the Colorado National Monument into a red-tinged blur.

Restricting sodium consumption important in lowering blood pressure among sedentary people

The more physically active you are, the less your blood pressure rises in response to a high-salt diet, researchers reported at the American Heart Association's Nutrition, Physical Activity and Metabolism/Cardiovascular Disease Epidemiology and Prevention 2011 Scientific Sessions.

Report on the U.S. Government's drive for comparative effectiveness research

MarketResearch.com has announced the addition of GlobalData's new report "The US Government's Financial Support to Push Comparative Effectiveness Research," to their collection of Healthcare market reports.

Impax reaches agreement with Endo and Penwest to settle pending litigation for OPANA ER

Impax Laboratories, Inc. today announced that it has reached agreement with Endo Pharmaceuticals and Penwest Pharmaceuticals to settle pending U.S. litigation with regard to the production and sale of generic formulations of OPANA ER (oxymorphone hydrochloride) Extended Release tablets.

Read more Medical News

› Verified 1 days ago